Stress Relief Supplements Market Expected to Grow at 6% CAGR until 2033

The global Stress Relief Supplements Market (ストレス解消サプリメント市場) is anticipated to achieve a valuation of US$ 950 million by the conclusion of 2033, exhibiting a Compound Annual Growth Rate (CAGR) of 6% over the subsequent decade. Everyday life pressures trigger an innate stress response within our bodies. Efficient stress management is crucial, directly impacting our mental well-being. While employing self-care techniques can effectively mitigate and handle stress, there are occasions where supplements become indispensable. These supplements offer a targeted dietary approach to alleviating stress. An array of information sources that delineate both the benefits and drawbacks of stress-relieving supplements aid consumers in selecting the most appropriate product format and type. Furthermore, the burgeoning stress levels across various age groups due to lifestyle changes have fueled a heightened demand for stress-relieving supplements. This trend is projected to persist throughout the forecast period.

For More Insights into the Market, Request a Sample of this Report:
https://www.factmr.com/connectus/sample?flag=S&rep_id=8894

Mounting global concerns regarding stress management are leading to a decline in healthcare efficacy, adversely affecting productivity during work hours, consequently resulting in diminished organizational revenues. Within the healthcare sector, there is a rapid surge in demand for sleeping aids and stress management supplements. Sleep deprivation emerges as a significant contributor to stress. Internationally, an increasing number of individuals are acknowledging the potential drawbacks of traditional stress management medications, fostering a heightened interest in herbal stress management supplements such as ashwagandha. Stress has become an omnipresent factor in modern life, affecting individuals of all ages and backgrounds. This widespread issue has led to a surge in the demand for stress relief supplements, driving significant growth in the global market. The market dynamics are shaped by the increasing awareness about mental health, rising disposable incomes, and the growing preference for natural and herbal remedies over pharmaceutical solutions.

Key Takeaways from Market Study

The global stress relief supplements market (스트레스 해소 보조제 시장) is valued at US$ 530 million in 2023.
Worldwide demand for stress relief supplements is projected to rise at a CAGR of 6% from 2023 to 2033.
The market is estimated to touch US$ 950 million by the end of 2033.
Ashwagandha dominates the market in terms of share as it enjoys extensive application in ayurvedic treatments.

Market Dynamics

The stress relief supplements market is driven by several factors, including the rising prevalence of stress-related disorders, such as anxiety and depression. Factors such as urbanization, hectic lifestyles, and work-related pressures have contributed to the increasing stress levels among individuals, thereby boosting the demand for stress relief supplements.

Moreover, the growing consumer preference for natural and organic products has led to an increase in the adoption of herbal stress relief supplements. These products are perceived as safer and more effective alternatives to pharmaceutical drugs, driving their demand in the market.

Market Future Outlook

The stress relief supplements market is expected to witness robust growth in the coming years, driven by increasing awareness about mental health and the growing acceptance of stress relief supplements as a part of a healthy lifestyle. Additionally, the market is likely to benefit from the introduction of innovative products with improved efficacy and safety profiles.

Key Players

Virtue Vitamins LIC
The Himalaya Drug Company
Ricola
Nutraceutical International Corporation
Cureveda
NaturesPlus
Pharmalinea Ltd.
ADM

Competitive Landscape

The global stress relief supplements market (Markt für Nahrungsergänzungsmittel zur Stresslinderung) is characterized by a competitive yet partially consolidated landscape, primarily shaped by established, large-scale companies that command a substantial market share. The industry dynamics reflect a mix of competition and collaboration, with key players striving for dominance while also seeking opportunities for product innovation and market expansion.

In December 2020, ASX-listed MGC Pharma began talks with countries in South East Asia to potentially introduce its scientifically validated oral supplement, known as ArtemiC, to the market for commercial use among COVID-19 patients.

Get Customization on this Report for Specific Research Solutions:
https://www.factmr.com/connectus/sample?flag=RC&rep_id=8894

Key Segments of Stress Relief Supplements Industry Research

By Source :

Ashwagandha

Chamomile

Lavender

Melatonin

Rhodiola

L-theanine

By Form :

Capsules & Tablets

Oil

Powder

By Category :

Organic

Conventional

By Distribution Channel :

Store-based [Supermarkets, Specialty Stores]

Non-store-based

By Region :

North America

Latin America

Europe

Asia Pacific

Middle East & Africa

Contact:

US Sales Office

11140 Rockville Pike

Suite 400 Rockville, MD 20852

United States Tel: +1 (628) 251-1583, +353-1-4434-232 (D)

Sales Team: sales@factmr.com

About Fact.MR :

We are a trusted research partner of 80% of fortune 1000 companies across the globe. We are consistently growing in the field of market research with more than 1000 reports published every year. The dedicated team of 400-plus analysts and consultants is committed to achieving the utmost level of our client's satisfaction.

This release was published on openPR.